Literature DB >> 33834388

Association of interleukin-12B rs6887695 with susceptibility to allergic rhinitis.

Sara Falahi1, Farhad Salari2, Alireza Rezaiemanesh2, Seyed Hamidreza Mortazavi3, Farzaneh Koohyanizadeh1, Ramin Lotfi4, Ali Gorgin Karaji5.   

Abstract

Interleukin-12 (IL-12) is a heterodimeric cytokine encoded by two separate genes, IL12A and IL12B, which may play a regulatory role in allergen-induced inflammation through CD4+ T-cell subsets polarization. The aim of this study was to investigate the association of single-nucleotide polymorphisms (SNPs) in the IL12B gene with susceptibility to allergic rhinitis (AR). We performed a case-control study including 130 AR patients and 130 healthy controls to evaluate the possible association between IL12B gene SNPs (rs3212227, rs6887695) and the risk of AR using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Our results showed no significant association between IL12B rs3212227 A > C polymorphism with AR. In contrast, the GC genotype of rs6887695 G > C was associated with susceptibility to AR in comparison with the GG genotype (p = 0.049, OR = 1.684, 95% CI: 1.002-2.83). We also observed a statistically significant difference in the additive model (GC versus GG + CC, p = 0.03, OR = 1.705, 95% CI: 1.040-2.794) for SNPs rs6887695. Furthermore, haplotypes analysis demonstrated that C-C haplotype was associated with an increased risk of AR (p = 0.01, OR = 1.845, 95% CI: 1.114-3.057). Our findings suggest that IL12B rs6887695 polymorphism may be a potential biomarker for susceptibility to AR in an Iranian population.

Entities:  

Keywords:  Allergic rhinitis; IL12B gene; Single-nucleotide polymorphism

Mesh:

Substances:

Year:  2021        PMID: 33834388     DOI: 10.1007/s12026-021-09189-1

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  28 in total

Review 1.  The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses.

Authors:  Giorgio Trinchieri; Stefan Pflanz; Robert A Kastelein
Journal:  Immunity       Date:  2003-11       Impact factor: 31.745

Review 2.  IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases.

Authors:  Michele W L Teng; Edward P Bowman; Joshua J McElwee; Mark J Smyth; Jean-Laurent Casanova; Andrea M Cooper; Daniel J Cua
Journal:  Nat Med       Date:  2015-06-29       Impact factor: 53.440

3.  Gallic acid alleviates nasal inflammation via activation of Th1 and inhibition of Th2 and Th17 in a mouse model of allergic rhinitis.

Authors:  Yanjing Fan; Chun Hua Piao; Eunjin Hyeon; Sun Young Jung; Ji-Eun Eom; Hee Soon Shin; Chang Ho Song; Ok Hee Chai
Journal:  Int Immunopharmacol       Date:  2019-03-16       Impact factor: 4.932

4.  Allergic Rhinitis: an Overview.

Authors:  Jitendra Varshney; Himanshu Varshney
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2015-01-31

5.  Interleukin-4 and interferon-gamma production in atopic and non-atopic children with asthma.

Authors:  M L Tang; J Coleman; A S Kemp
Journal:  Clin Exp Allergy       Date:  1995-06       Impact factor: 5.018

Review 6.  Interleukin-12 and the regulation of innate resistance and adaptive immunity.

Authors:  Giorgio Trinchieri
Journal:  Nat Rev Immunol       Date:  2003-02       Impact factor: 53.106

Review 7.  Discovering susceptibility genes for allergic rhinitis and allergy using a genome-wide association study strategy.

Authors:  Jingyun Li; Yuan Zhang; Luo Zhang
Journal:  Curr Opin Allergy Clin Immunol       Date:  2015-02

8.  Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon gamma) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects.

Authors:  S Ying; S R Durham; C J Corrigan; Q Hamid; A B Kay
Journal:  Am J Respir Cell Mol Biol       Date:  1995-05       Impact factor: 6.914

9.  Neutralization of interleukin-17 suppresses allergic rhinitis symptoms by downregulating Th2 and Th17 responses and upregulating the Treg response.

Authors:  Zhao Wei Gu; Yun Xiu Wang; Zhi Wei Cao
Journal:  Oncotarget       Date:  2017-04-04

10.  Risk factors of allergic rhinitis: genetic or environmental?

Authors:  De-Yun Wang
Journal:  Ther Clin Risk Manag       Date:  2005-06       Impact factor: 2.423

View more
  1 in total

Review 1.  Semaphorin-3A: a promising therapeutic tool in allergic rhinitis.

Authors:  Ramin Lotfi; Nahid Zamanimehr
Journal:  Immunol Res       Date:  2022-01-14       Impact factor: 2.829

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.